Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2002
01/31/2002US20020012954 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
01/31/2002US20020012953 Recovering preferential aggregations; obtain sample, incubate with ligand, evaluate optically and detect binding
01/31/2002US20020012952 Method for detecting hemolysis
01/31/2002US20020012951 Method of screening for specific binding interactions
01/31/2002US20020012950 Screening for tumor metastasis; monitor sample for tumor marker protein expression, compare to control, evaluate tumor metastasis
01/31/2002US20020012949 Assay systems for leptin-enhancing agents
01/31/2002US20020012948 Metallopeptide combinatorial libraries and applications
01/31/2002US20020012947 Complexing
01/31/2002US20020012946 Method of identifying partial agonists of the A2A receptor
01/31/2002US20020012945 Contacting with a binding partner which specifically binds a protease but does not block the active center and is or can be bound to a solid phase, a substrate specific for the protease, and a reaction buffer, and determining chromogen
01/31/2002US20020012944 Pai-2 and t-pa as diagnostic markers of periodontal disease
01/31/2002US20020012943 Electrochemical probes for detection of molecular interactions and drug discovery
01/31/2002US20020012940 Monitoring preferential expression; provide a pool of target ribonucleic acid sequences, hybridize to immobilized probes, measure nucleic acid hybridization to soild support
01/31/2002US20020012937 Microelectronic device and method for label-free detection and quantification of biological and chemical molecules
01/31/2002US20020012936 Test sample treated with a base and incubated with nucleic acid probes, diluted in a neutralizing buffer, specific for target nucleic acids. The hybrids are captured onto a solid phase coated with an anti-hybrid antibody fragment
01/31/2002US20020012935 Composition for the generation biochips or a substrate immobilized with a biopolymer
01/31/2002US20020012933 Annealing a population of circular nucleic acid molecules to a anchor primers linked to a solid support, and amplifying those molecules which anneal to the target nucleic acid, and then sequencing the amplified molecules
01/31/2002US20020012931 High specificity marker detection
01/31/2002US20020012930 Method of sequencing a nucleic acid
01/31/2002US20020012929 Confining preferential particles to soild support; obtain sample, pour over support, allow binding, eluting bound particles, recover eluted particles
01/31/2002US20020012926 Monitoring preferential nucleotide sequences hybridization in sample; obtain nucleotide sequences and mix with probes, incubate, separate and recover hybridized nucleotide sequences
01/31/2002US20020012923 Detection of binding of charged species using pH- or potential-sensitive probes
01/31/2002US20020012922 Simultaneous sequence-specific identification and display of mRNA molecules in RNA population.
01/31/2002US20020012920 Analyzing proteins in sample; separate protein, transfer to membranes, incubate with ligand, detect binding
01/31/2002US20020012919 Nucleic acids of rochalimaea henselae and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
01/31/2002US20020012918 Methods and compositions for detection of mycobacterium avium complex species
01/31/2002US20020012916 A method of reducing contamination in an essay vessel
01/31/2002US20020012915 Hybridizing at least one selected single strand sequence with a complementary single strand nucleic acid and a crosslinking agent; COBRA method for the labeling of a set of bio-organic molecules with a set of colors
01/31/2002US20020012913 Detecting polymorphism in preferential nucleotide sequences; provide probe arrays, hybridize target nucleotide sequences and determine pattern, hybridize control and determine pattern, compare patterns and detect polymorphism
01/31/2002US20020012912 Parallel combinatorial libraries for chiral selectors
01/31/2002US20020012911 Screening sample libraries for preferential nucleotide sequences; provide library, amplify, transfer nucleotide sequences to carrier, bind label, detect nucleotide sequences, evaluate signal from nucleotide sequences
01/31/2002US20020012907 Methods for simultaneously detecting both members of a binding pair
01/31/2002US20020012906 Method for kidney disease treatment by drug intervention
01/31/2002US20020012905 Generating profile of preferential chemical intermediates; incubate liver stem cells with chemical intermediate, monitor cells, detect adjustments in gene expression, classify respones to chemical intermediate
01/31/2002US20020012904 Analysing extracellular hemoglobin; determine hemoglobin concentration of sample, determine cellular hemoglobin concentration, determine extracellular hemoglobin concentration
01/31/2002US20020012902 Methods and kit for hybridization analysis using peptide nucleic acid probes
01/31/2002US20020012699 Providing membrane protein in solution, providing solution of preformed liposomes formed by combining mixture of phospholipids with solution of unsaturated fatty acid, incubating
01/31/2002US20020012668 Used in diagnostics, detection of the bacteria Salmonella.typhi or in the production of vaccines for typhoid fever
01/31/2002US20020012664 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian CC-chemokine receptor 2, mammalian CC-chemokine receptor 2 or ligand-binding variant, measuring binding
01/31/2002US20020012658 Prevention and treatment of verotoxin-induced disease
01/31/2002US20020012637 Administering to the oral cavity of a human or animal one or more lactic bacteria that are not part of resident microflora of mouth, that are low acidifying, and that are capable of adhering directly to pellicle of teeth
01/31/2002US20020012630 Producing wound in skin or another external body surface of an animal; permitting wound to heal in absence of test compound, or treating wound with a test compound; comparing wound healing, identifying a compound improves healing
01/31/2002US20020012456 Method and apparatus for providing a bioinformatics database
01/31/2002US20020012448 Use of a scanner to determine the optical density of calcined coke as a measure of coke quality
01/31/2002US20020012419 Analysis of samples
01/31/2002US20020011928 Programmable microwave back-up warning system and method
01/31/2002US20020011851 Process and device for detecting oxidizable and/or reducible gasses in air
01/31/2002US20020011569 Stable isotope measurement method and apparatus by spectroscopy
01/31/2002US20020011567 Apparatus and method and techniques for measuring and correlating characteristics of fruit with visible/near infra-red spectrum
01/31/2002US20020011492 Collection container assembly
01/31/2002US20020011449 Systems and methods for sensing red blood cell hematocrit
01/31/2002US20020011408 Microchip-based carbon dioxide gas sensor
01/31/2002US20020011357 Fluid drilling system with drill string and retro jets
01/31/2002US20020011266 On-line sensor for colloidal substances
01/31/2002US20020011095 Combined oil quality and viscosity sensing system
01/31/2002US20020011069 Method and configuration for cleaning an exhaust-gas flow flowing in an exhaust system of a gasoline engine
01/31/2002DE10126055A1 Biosensor Biosensor
01/31/2002DE10115781A1 Verfahren und Anlage zum sortengerechten Separieren von Kunststoffen aus aufbereiteten Kunststoffgemischen Method and apparatus for separating species equitable plastics from recycled plastic mixtures
01/31/2002DE10036072A1 Device for detecting variations in properties of bonds in single molecules, e.g. determining the redox potential of biomolecules, has nanoelectrodes with gap between and nano gaps between these through which electrons can tunnel
01/31/2002DE10035953A1 Sphärische, magnetische Silica-Partikel mit einstellbarer Teilchen- und Porengröße sowie einstellbarem Magnetgehalt für die Aufreinigung von Nukleinsäuren und anderen Biomolekülen Spherical magnetic silica particles with adjustable particle and pore size as well as an adjustable magnetic content for purification of nucleic acids and other biomolecules
01/31/2002DE10035227A1 Selection and use of lipogenesis inhibitors for the treatment and prevention of obesity
01/31/2002DE10035106A1 Verfahren zum Nachweis des Effektes einer Substanz auf lebende Zellen A method for detecting the effect of a substance on living cells
01/31/2002DE10034804A1 Verwendung von VLCFAE zum Identifizieren von herbizid wirksamen Verbindungen Using VLCFAE for identifying herbicidally active compounds
01/31/2002DE10034496A1 Blutgruppenserologisches Untersuchungsverfahren Blutgruppenserologisches investigation procedure
01/31/2002DE10032290A1 Adsorptionsmittelhaltige Kontrollflüssigkeit Adsorptionsmittelhaltige control liquid
01/31/2002DE10029781A1 Monitoring the optical characteristics of a paper web on a carrier, to register web breaks, uses light beams of different wavelengths to be received for brightness values for comparison with a set threshold value
01/31/2002CA2763114A1 Multi-well plate and electrode assemblies for ion channel assay methods
01/31/2002CA2763047A1 High throughput device for screening candidate compounds for activity against target ion channels
01/31/2002CA2725819A1 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
01/31/2002CA2418282A1 Compounds and methods for treatment and diagnosis of chlamydial infection
01/31/2002CA2418217A1 Identifying antigen clusters for monitoring a global state of an immune system
01/31/2002CA2418198A1 Novel protein containing ring finger domaine r1p4
01/31/2002CA2417223A1 A novel member of the epha receptor family
01/31/2002CA2417134A1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases
01/31/2002CA2417075A1 Detection of abnormalities leading to cervical malignancy
01/31/2002CA2417005A1 Regulators of ppar.delta.(.beta.) and their use in the treatment of obesity and insulin resistance
01/31/2002CA2416764A1 Methods, systems, and articles of manufacture for evaluating biological data
01/31/2002CA2416761A1 Method for screening peptides for use in immunotherapy
01/31/2002CA2416755A1 Lrp-mediated modulation of neuronal calcium influx via nmda receptors, and uses thereof
01/31/2002CA2416733A1 Nk cells activating receptors and their therapeutic and diagnostic uses
01/31/2002CA2416713A1 Novel siglecs and uses thereof
01/31/2002CA2416708A1 A systematic approach to mechanism-of-response analyses
01/31/2002CA2416691A1 Proteases
01/31/2002CA2416676A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof
01/31/2002CA2416664A1 Zinc finger domain recognition code and uses thereof
01/31/2002CA2416657A1 Fh-binding protein of streptococcus pneumoniae
01/31/2002CA2416647A1 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
01/31/2002CA2416611A1 Methods and systems for evaluating a matching between measured data and standards
01/31/2002CA2416544A1 Mu-conopeptides
01/31/2002CA2416517A1 A method for ab initio determination of macromolecular crystallographic phases using bessel function
01/31/2002CA2416456A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/31/2002CA2416414A1 Human kinases
01/31/2002CA2416381A1 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
01/31/2002CA2416375A1 Method of identifying cancer markers and uses therefor in the diagnosis of cancer
01/31/2002CA2415361A1 Method and apparatus for assessing or predicting characteristics of wood or other wooden materials
01/31/2002CA2415306A1 Accessibility correction factors for electronic models of cytochrome p450 metabolism
01/31/2002CA2415077A1 Cell cycle proteins and mitosis-associated molecules
01/31/2002CA2414215A1 New methods and kits for sequencing polypeptides
01/31/2002CA2407721A1 Coupling elements for surface plasmon resonance sensors
01/31/2002CA2353106A1 A pcr-based multiplex assay for determining haplotype